Bronchial asthma can be triggered by microbial agents in the oropharynx. This study was designed to identify the differences in microbiota of oropharynx of bronchial asthmatic patients in contrast to normal controls. In order to resolve the qualitative and quantitative diversity of the 16S rRNA gene present in the oropharynx microbiota of 4 patients and 4 controls, we compared microbial communities using Sanger sequencing and 376 sequences of 16S rRNA gene were analyzed. Of the total microbial diversity detected in the oropharynx in asthmatic patients 45.6% comprised members of the Firmicutes. In contrast, Proteobacteria (44.0%) dominated the oropharyngeal microbiota in the normal control group. Members of the Bacteroidetes, Fusobacteria, Actinobacteria, TM7, Cyanobacteria and unclassified bacteria were present in both groups. In conclusion, the difference in the microbiota of the oropharynx between patients and normal individuals could trigger symptomatic attacks in bronchial asthma.
INTRODUCTION
Asthma is a heterogeneous syndrome of airway inflammation with an increasing incidence in populations around the world. Its heterogeneity contributes to the undetermined pathogenesis in its development and frequent exacerbation.
Chronic infections cause a decline in lung function and may be a risk factor for the development and triggering of bronchial asthma. The association between respiratory infections and atopy or asthma remains to be determined and may be highly dependent on different infectious agents (1) .
Respiratory infections caused by respiratory syncytial virus (RSV), rhinovirus, parainfluenzavirus, influenzavirus and metapneumovirus may be associated with childhood wheezing and exacerbation of asthma (2) . Atypical bacterial pathogens such as Chlamydophila pneumoniae and Mycoplasma pneumoniae may also be associated with asthma (3~6). Most studies so far have been on childhood asthma. But there have only been a few studies explaining the association between respiratory microbes and adulthood asthma.
Human microbiota are diverse in their structure and function across individuals and different sites. The micro-
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Original Article biota in the gastrointestinal tracts have been related to inflammatory bowel diseases (7) and obesity, (8) while atherosclerosis (9) has been linked to the oral microbiota.
Oral microbial environments are known to be linked to upper and lower respiratory infections (7) , which can also precipitate into atopic airway diseases such as allergic rhinitis and/or bronchial asthma.
The clinical relevance of the microbiota on the oropharyngeal wall is unknown. But it is known that the changes in diversity of the oral microbiota can be induced by use of antibiotics, probiotics, diet, and also influenced by microbiota in the gut. Changes in the microbiota of GI tracts can affect mucosal immunity in the lungs, as well as the gut, by bystander suppression (10) . The link between oral and airway tolerance may be related to the induction or suppression of systemic immune tolerance in a way to challenge antigens. Therefore, defining the characteristics of the oropharyngeal microbiota may lead to understanding new pathogenic roles of these microorganisms and the discovery of novel therapies for the prevention and treatment of oral complications (11) .
The oral microbiota is a critical component in health and disease, even the normal healthy lung is not a sterile organ, in contrast to previous assumptions (12) . In order to access such low or less dominant population culture-independent strategies must inevitably be introduced for the analysis of microbial ecology.
In the current study a metagenomics approach is used to characterize the microbial populations of the oropharyngeal larynx. This approach involves the genomic analysis of microorganisms by direct extraction and sequencing of DNA from their natural environment (13) . In this study, we have developed a method based on 16S rRNA gene amplification followed by clonal Sanger sequencing for monitoring the microbial communities. A highly variable region (V1-V3) of the 16S rRNA gene is amplified using primers that target adjacent conserved regions, followed by direct sequencing of individual PCR products. Here we demonstrate the power of this method by exploring the diversity within the human oropharyngeal ecosystem.
MATERIALS AND METHODS

Study participants and sample preparation
We selected 4 controls from Chung-Ang University College of Medicine (CAU) and 4 patients with bronchial asthma in Chung-Ang University Hospital (Table 1) Those with bronchial asthma had mild intermittent disease severity and were treated as naive. Each swab sample was aseptically placed in a microfuge tube, centrifuged for 10 min., and the supernatant was removed. To detect possible contamination, negative controls were prepared and then subjected to the same procedures.
DNA extraction from oropharyngeal swab samples
The first step in the analysis was extraction of DNA from the bacterial pellet obtained from oropharyngeal swab samples followed by PCR analysis. Samples were extracted individually using the cetyltrimethylammonium bromide 
Statistical analysis
Factor analysis was applied in order to extract meaningful variables from the total observed set of variables.
Principal components were identified with over 70% of the cumulative variance. The component matrix of the chosen principal components was calculated and variables whose factor loadings were below 0.6 deleted. A Generalized Linear Model (GLM) using the final set of chosen variables was constructed. The following equation (a) represents the GLM,
where, t is the total number of Occurrences, χ = and g (μ) = log (μ/t) in the pooled group of samples from asthma patients and healthy controls.
The parameter beta is tested at a 5% significance level by (a).
RESULTS
Identification of genera in the asthma patient and control groups
The diversity of the oropharyngeal swab To examine the diversity of the microbial community present in oropharyngeal swab samples, assembled sequences were assigned to bacterial genera based on the taxonomy of their closest relatives as judged by BLAST n analysis.
While the two data sets show broad taxonomic similarity, there is however a notable variation in each sample at species level.
It should be noted however, that this analysis is coveragelimited. To correlate the variation of bacteria between the swab samples, the BLAST n hits were classified by genera. Fig. 1 and Streptobacillus spp. were detected in the bronchial asthma oropharynx samples and were absent in the nonasthmatic controls.
Identification of different phyla in the asthma patient and non-asthmatic persons
Seven bacterial phyla were detected, but most sequences were assigned to three phyla: Firmicutes (45.6%), Proteo- 
UniFrac and statistical analysis
Jackknife clustering of environments (Fig. 3a) showed fairly robust clustering (75% bootstrap on all nodes but one) in the bronchial asthma and non-asthmatic samples; it is similar to the PCA. Comparison of the individual samples using Fast UniFrac PCA (Fig. 3b) showed a distinct clustering by dietary treatment, when both the DNA samples were included in the analysis.
Statistical analysis showed significantly different frequencies between the bronchial asthma and non-asthmatic samples ( Table 2) Recently, the correlation of the presence of combined Veillonella and Streptococcus abundances in atherosclerotic plaque samples and in oral samples across patients has been studied (27) . These two genera are known early colonizers of tooth surfaces that interact to form dental plaques:
Streptococcus produces a preferred fermentation product for Veillonella (28) . In addition, Prevotella was found in bronchial asthma patients. Our results suggest that the distribution and profile of bacterial species in the oropharynx of normal control individuals is complex, and it is important 
